Describing how your medicine will be uniquely differentiated in the market so that it has the highest probability to be:
Approved
Paid For
Prescribed
Taken over all other alternatives
Our solution includes a HealthCare Differentiation Indicator and various Differentiation scores that compare your asset on pre-determined Disease Area parameters to
other current and future competing products.
|
 |
Demonstrating how strongly your medicine addresses real unmet needs in the market for:
Patients
Prescribers
Approvers
Payers
Caregivers
The MDA Methodology ensures optimal Label Claims are driven from Unmet Customer Needs.
|
 |
Providing the likelihood your medicine will bring the highest Return on Investment (ROI) over other alternatives in your portfolio. The MDA Methodology includes an evaluation of:
How real the opportunity is - that your medicine directly addresses a significant unmet need
The likelihood your asset will win in the market against other alternatives
The financial worth of the life cycle investment
|